カテゴリー： Market Monitor Global, 世界, 医療/バイオ

胃食道逆流症治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Gastroesophageal Reflux Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5579）◆商品コード：MMG23JU5579
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Gastroesophageal Reflux Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの胃食道逆流症治療薬市場規模と予測を収録しています。・世界の胃食道逆流症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の胃食道逆流症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の胃食道逆流症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「エソメプラゾール」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

胃食道逆流症治療薬のグローバル主要企業は、Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxinなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、胃食道逆流症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の胃食道逆流症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の胃食道逆流症治療薬市場：タイプ別市場シェア、2022年
・エソメプラゾール、ランソプラゾール、オメプラゾール、ルベプラゾール、デクスランソプラゾール、その他

世界の胃食道逆流症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の胃食道逆流症治療薬市場：用途別市場シェア、2022年
・病院、外来手術センター、専門クリニック、その他

世界の胃食道逆流症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の胃食道逆流症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における胃食道逆流症治療薬のグローバル売上、2018年-2023年
・主要企業における胃食道逆流症治療薬のグローバル売上シェア、2022年
・主要企業における胃食道逆流症治療薬のグローバル販売量、2018年-2023年
・主要企業における胃食道逆流症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxin

*************************************************************

・調査・分析レポートの概要
胃食道逆流症治療薬市場の定義
市場セグメント
世界の胃食道逆流症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の胃食道逆流症治療薬市場規模
世界の胃食道逆流症治療薬市場規模：2022年 VS 2029年
世界の胃食道逆流症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの胃食道逆流症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の胃食道逆流症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：エソメプラゾール、ランソプラゾール、オメプラゾール、ルベプラゾール、デクスランソプラゾール、その他
胃食道逆流症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、外来手術センター、専門クリニック、その他
胃食道逆流症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別胃食道逆流症治療薬市場規模 2022年と2029年
地域別胃食道逆流症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxin
...

Gastroesophageal Reflux Disease (GERD) is a digestive disorder that occurs when acidic stomach juices, or food and fluids back up from the stomach into the esophagus.GERD affects people of all ages—from infants to older adults. People with asthma are at higher risk of developing GERD.
This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Drugs. This report contains market size and forecasts of Gastroesophageal Reflux Drugs in global, including the following market information:
Global Gastroesophageal Reflux Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastroesophageal Reflux Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gastroesophageal Reflux Drugs companies in 2022 (%)
The global Gastroesophageal Reflux Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Esomeprazole Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastroesophageal Reflux Drugs include Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda and NCPC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastroesophageal Reflux Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroesophageal Reflux Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Drugs Market Segment Percentages, by Type, 2022 (%)
Esomeprazole
Lansoprazole
Omeprazole
Rbeprazole
Dexlansoprazole
Others
Global Gastroesophageal Reflux Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory surgical centers
Specialty clinics
Others
Global Gastroesophageal Reflux Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroesophageal Reflux Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastroesophageal Reflux Drugs revenues share in global market, 2022 (%)
Key companies Gastroesophageal Reflux Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastroesophageal Reflux Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastroesophageal Reflux Drugs, market overview.
Chapter 2: Global Gastroesophageal Reflux Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastroesophageal Reflux Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastroesophageal Reflux Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastroesophageal Reflux Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Gastroesophageal Reflux Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastroesophageal Reflux Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastroesophageal Reflux Drugs Overall Market Size
2.1 Global Gastroesophageal Reflux Drugs Market Size: 2022 VS 2029
2.2 Global Gastroesophageal Reflux Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gastroesophageal Reflux Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gastroesophageal Reflux Drugs Players in Global Market
3.2 Top Global Gastroesophageal Reflux Drugs Companies Ranked by Revenue
3.3 Global Gastroesophageal Reflux Drugs Revenue by Companies
3.4 Global Gastroesophageal Reflux Drugs Sales by Companies
3.5 Global Gastroesophageal Reflux Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastroesophageal Reflux Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastroesophageal Reflux Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastroesophageal Reflux Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gastroesophageal Reflux Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gastroesophageal Reflux Drugs Market Size Markets, 2022 & 2029
4.1.2 Esomeprazole
4.1.3 Lansoprazole
4.1.4 Omeprazole
4.1.5 Rbeprazole
4.1.6 Dexlansoprazole
4.1.7 Others
4.2 By Type – Global Gastroesophageal Reflux Drugs Revenue & Forecasts
4.2.1 By Type – Global Gastroesophageal Reflux Drugs Revenue, 2018-2023
4.2.2 By Type – Global Gastroesophageal Reflux Drugs Revenue, 2024-2029
4.2.3 By Type – Global Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Gastroesophageal Reflux Drugs Sales & Forecasts
4.3.1 By Type – Global Gastroesophageal Reflux Drugs Sales, 2018-2023
4.3.2 By Type – Global Gastroesophageal Reflux Drugs Sales, 2024-2029
4.3.3 By Type – Global Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Gastroesophageal Reflux Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gastroesophageal Reflux Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ambulatory surgical centers
5.1.4 Specialty clinics
5.1.5 Others
5.2 By Application – Global Gastroesophageal Reflux Drugs Revenue & Forecasts
5.2.1 By Application – Global Gastroesophageal Reflux Drugs Revenue, 2018-2023
5.2.2 By Application – Global Gastroesophageal Reflux Drugs Revenue, 2024-2029
5.2.3 By Application – Global Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Gastroesophageal Reflux Drugs Sales & Forecasts
5.3.1 By Application – Global Gastroesophageal Reflux Drugs Sales, 2018-2023
5.3.2 By Application – Global Gastroesophageal Reflux Drugs Sales, 2024-2029
5.3.3 By Application – Global Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Gastroesophageal Reflux Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gastroesophageal Reflux Drugs Market Size, 2022 & 2029
6.2 By Region – Global Gastroesophageal Reflux Drugs Revenue & Forecasts
6.2.1 By Region – Global Gastroesophageal Reflux Drugs Revenue, 2018-2023
6.2.2 By Region – Global Gastroesophageal Reflux Drugs Revenue, 2024-2029
6.2.3 By Region – Global Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Gastroesophageal Reflux Drugs Sales & Forecasts
6.3.1 By Region – Global Gastroesophageal Reflux Drugs Sales, 2018-2023
6.3.2 By Region – Global Gastroesophageal Reflux Drugs Sales, 2024-2029
6.3.3 By Region – Global Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gastroesophageal Reflux Drugs Revenue, 2018-2029
6.4.2 By Country – North America Gastroesophageal Reflux Drugs Sales, 2018-2029
6.4.3 US Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.4.4 Canada Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.4.5 Mexico Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gastroesophageal Reflux Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Gastroesophageal Reflux Drugs Sales, 2018-2029
6.5.3 Germany Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.5.4 France Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.5.5 U.K. Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.5.6 Italy Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.5.7 Russia Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.5.9 Benelux Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gastroesophageal Reflux Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Gastroesophageal Reflux Drugs Sales, 2018-2029
6.6.3 China Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.6.4 Japan Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.6.5 South Korea Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.6.7 India Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gastroesophageal Reflux Drugs Revenue, 2018-2029
6.7.2 By Country – South America Gastroesophageal Reflux Drugs Sales, 2018-2029
6.7.3 Brazil Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.7.4 Argentina Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gastroesophageal Reflux Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gastroesophageal Reflux Drugs Sales, 2018-2029
6.8.3 Turkey Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.8.4 Israel Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gastroesophageal Reflux Drugs Market Size, 2018-2029
6.8.6 UAE Gastroesophageal Reflux Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Gastroesophageal Reflux Drugs Major Product Offerings
7.1.4 Bayer Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Company Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Cadila Pharmaceuticals Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Gastroesophageal Reflux Drugs Major Product Offerings
7.3.4 AstraZeneca Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Jiangsu Aosaikang
7.4.1 Jiangsu Aosaikang Company Summary
7.4.2 Jiangsu Aosaikang Business Overview
7.4.3 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Major Product Offerings
7.4.4 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Jiangsu Aosaikang Key News & Latest Developments
7.5 Eisai
7.5.1 Eisai Company Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Gastroesophageal Reflux Drugs Major Product Offerings
7.5.4 Eisai Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Eisai Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Gastroesophageal Reflux Drugs Major Product Offerings
7.6.4 Pfizer Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Altana Pharma
7.7.1 Altana Pharma Company Summary
7.7.2 Altana Pharma Business Overview
7.7.3 Altana Pharma Gastroesophageal Reflux Drugs Major Product Offerings
7.7.4 Altana Pharma Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Altana Pharma Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Gastroesophageal Reflux Drugs Major Product Offerings
7.8.4 Takeda Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 NCPC
7.9.1 NCPC Company Summary
7.9.2 NCPC Business Overview
7.9.3 NCPC Gastroesophageal Reflux Drugs Major Product Offerings
7.9.4 NCPC Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.9.5 NCPC Key News & Latest Developments
7.10 Luoxin
7.10.1 Luoxin Company Summary
7.10.2 Luoxin Business Overview
7.10.3 Luoxin Gastroesophageal Reflux Drugs Major Product Offerings
7.10.4 Luoxin Gastroesophageal Reflux Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Luoxin Key News & Latest Developments
8 Global Gastroesophageal Reflux Drugs Production Capacity, Analysis
8.1 Global Gastroesophageal Reflux Drugs Production Capacity, 2018-2029
8.2 Gastroesophageal Reflux Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastroesophageal Reflux Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastroesophageal Reflux Drugs Supply Chain Analysis
10.1 Gastroesophageal Reflux Drugs Industry Value Chain
10.2 Gastroesophageal Reflux Drugs Upstream Market
10.3 Gastroesophageal Reflux Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastroesophageal Reflux Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Gastroesophageal Reflux Drugs in Global Market
Table 2. Top Gastroesophageal Reflux Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastroesophageal Reflux Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastroesophageal Reflux Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gastroesophageal Reflux Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Gastroesophageal Reflux Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastroesophageal Reflux Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gastroesophageal Reflux Drugs Product Type
Table 9. List of Global Tier 1 Gastroesophageal Reflux Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gastroesophageal Reflux Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastroesophageal Reflux Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gastroesophageal Reflux Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Gastroesophageal Reflux Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gastroesophageal Reflux Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastroesophageal Reflux Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gastroesophageal Reflux Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Gastroesophageal Reflux Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gastroesophageal Reflux Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastroesophageal Reflux Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gastroesophageal Reflux Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Gastroesophageal Reflux Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gastroesophageal Reflux Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Gastroesophageal Reflux Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gastroesophageal Reflux Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gastroesophageal Reflux Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gastroesophageal Reflux Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gastroesophageal Reflux Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gastroesophageal Reflux Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Gastroesophageal Reflux Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gastroesophageal Reflux Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gastroesophageal Reflux Drugs Sales, (K Units), 2024-2029
Table 46. Bayer Company Summary
Table 47. Bayer Gastroesophageal Reflux Drugs Product Offerings
Table 48. Bayer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Cadila Pharmaceuticals Company Summary
Table 51. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Product Offerings
Table 52. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Cadila Pharmaceuticals Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Gastroesophageal Reflux Drugs Product Offerings
Table 56. AstraZeneca Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Jiangsu Aosaikang Company Summary
Table 59. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Product Offerings
Table 60. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Jiangsu Aosaikang Key News & Latest Developments
Table 62. Eisai Company Summary
Table 63. Eisai Gastroesophageal Reflux Drugs Product Offerings
Table 64. Eisai Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Eisai Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Gastroesophageal Reflux Drugs Product Offerings
Table 68. Pfizer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Altana Pharma Company Summary
Table 71. Altana Pharma Gastroesophageal Reflux Drugs Product Offerings
Table 72. Altana Pharma Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Altana Pharma Key News & Latest Developments
Table 74. Takeda Company Summary
Table 75. Takeda Gastroesophageal Reflux Drugs Product Offerings
Table 76. Takeda Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Takeda Key News & Latest Developments
Table 78. NCPC Company Summary
Table 79. NCPC Gastroesophageal Reflux Drugs Product Offerings
Table 80. NCPC Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. NCPC Key News & Latest Developments
Table 82. Luoxin Company Summary
Table 83. Luoxin Gastroesophageal Reflux Drugs Product Offerings
Table 84. Luoxin Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Luoxin Key News & Latest Developments
Table 86. Gastroesophageal Reflux Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Gastroesophageal Reflux Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Gastroesophageal Reflux Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Gastroesophageal Reflux Drugs Production by Region, 2024-2029 (K Units)
Table 90. Gastroesophageal Reflux Drugs Market Opportunities & Trends in Global Market
Table 91. Gastroesophageal Reflux Drugs Market Drivers in Global Market
Table 92. Gastroesophageal Reflux Drugs Market Restraints in Global Market
Table 93. Gastroesophageal Reflux Drugs Raw Materials
Table 94. Gastroesophageal Reflux Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Gastroesophageal Reflux Drugs Downstream
Table 96. Gastroesophageal Reflux Drugs Downstream Clients in Global Market
Table 97. Gastroesophageal Reflux Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastroesophageal Reflux Drugs Segment by Type in 2022
Figure 2. Gastroesophageal Reflux Drugs Segment by Application in 2022
Figure 3. Global Gastroesophageal Reflux Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastroesophageal Reflux Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastroesophageal Reflux Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Gastroesophageal Reflux Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gastroesophageal Reflux Drugs Revenue in 2022
Figure 9. By Type - Global Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Gastroesophageal Reflux Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Gastroesophageal Reflux Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gastroesophageal Reflux Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 23. US Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 28. Germany Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 37. China Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gastroesophageal Reflux Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gastroesophageal Reflux Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gastroesophageal Reflux Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gastroesophageal Reflux Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Gastroesophageal Reflux Drugs by Region, 2022 VS 2029
Figure 54. Gastroesophageal Reflux Drugs Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 胃食道逆流症治療薬の世界市場見通し2023年-2029年(Gastroesophageal Reflux Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 胃食道逆流症治療装置の世界市場見通し2023年-2029年
  • 胃食道逆流症治療の世界市場2022年～2029年：医薬品別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆